Latest Quarterly Activities News

The ASX has published its latest list of entities suspended from trading for over three months, detailing looming deadlines for overdue financial reports and plans to resume trading. Non-compliance risks removal from the official list.

Elevra Lithium’s North American Lithium operation posted a 15% production increase in June 2026, setting a monthly record in May. While sales prices lagged behind spot rates due to legacy contracts, the company expects future pricing to improve as these contracts conclude.

EQ Resources delivered its strongest quarterly tungsten output since early 2024, alongside record sales driven by higher prices and volumes, despite some operational hiccups in Spain.

Alkane Resources delivered 42,491 ounces gold equivalent in the June quarter, pushing full-year production to 168,337 ounces and bolstering cash and investments to $454 million.

Fenix Resources delivered a record 1.3 million tonnes shipment in June quarter, meeting FY26 guidance with 4.4 million tonnes and setting a 14% higher FY27 target while holding costs steady.

Greatland Resources beat its FY26 gold production guidance by 6%, delivering 329,000 ounces and building cash reserves to $1.29 billion while maintaining zero debt.

Cann Group has boosted its private credit loan facility by $2 million to facilitate the early redemption of convertible notes, maintaining its debt restructuring momentum.

Boss Energy has delivered on its revised FY26 uranium production guidance with 1.41 million pounds of U3O8 and accelerated its feasibility study for the Honeymoon project, aiming to unlock future growth with a new life-of-mine plan by August 2026.

LTR Pharma has confirmed it disclosed a binding US commercialisation agreement for ROXUS promptly after signing, responding to ASX scrutiny over pre-announcement trading activity.

Native Mineral Resources Holdings Limited produced nearly 398 ounces of gold doré in its latest Blackjack smelt, with mining and processing activities progressing on schedule and larger campaigns expected next month.

Jindalee Lithium has locked in a strongly supported A$11 million capital raise through a placement and entitlement offer to fund its McDermitt Lithium Project and the proposed NASDAQ listing of US Elemental Inc.

Nova Eye Medical has smashed its US sales record in April 2026, prompting an upgrade to its FY26 sales guidance and marking a milestone with positive operational EBITDA.